Production (Stage)
Biocure Technology Inc.
BICTF
$0.01
$0.0086614.29%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 141.00K | 1.20K | 41.00K | 46.90K | 615.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 141.00K | 1.20K | 41.00K | 46.90K | 615.50K |
| Operating Income | -141.00K | -1.20K | -41.00K | -46.90K | -615.50K |
| Income Before Tax | -149.80K | -6.60K | -14.70K | -17.60K | -2.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -149.80K | -6.60K | -14.70K | -17.60K | -2.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -26.80K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 2.10K |
| Net Income | -149.80K | -6.60K | -14.70K | -17.60K | -2.95M |
| EBIT | -141.00K | -1.20K | -41.00K | -46.90K | -615.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | -0.28 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 | -0.04 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | -0.28 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 | -0.04 |
| Average Basic Shares Outstanding | 10.44M | 81.60M | 9.07M | 10.32M | 10.44M |
| Average Diluted Shares Outstanding | 10.44M | 81.60M | 9.07M | 10.32M | 10.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |